Dermtech Inc (DMTK) Gross Profit Margin starting from the first quarter 2024 to first quarter 2023, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Dermtech Inc   (NASDAQ: DMTK)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Dermtech Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DMTK Gross Profit Margin (Mar 31 2024)
Q1 		(Dec 31 2023)
Q4 		(Sep 30 2023)
Q3 		(Jun 30 2023)
Q2 		(Mar 31 2023)
Q1
Y / Y Revenue Change 6.79 %
Seq. Revenue Change -5.38 %
Revenue In Millions $3.71
Gross Profit Margin 19.2 %
Gross Profit Margin Total Ranking # 3232
Gross Profit In Millions $0.71
Y / Y Gross Profit Change -
Seq. Gross Profit Change 62.05 %


Commenting First Quarter 2024 Gross Profit Margin
Dermtech Inc achieved Gross Profit of $1 millions compare to Gross Loss of $0.44 millions booked in the previous quarter. Despite the sequential Revenue deterioration in Q1 of -5.38 % Dermtech Inc managed to reduce Cost of Sales and increase Gross Profit by 62.05 % to $1 millions. Gross Profit Margin grew to 19.2 %, above company average Gross Profit Margin.


Observing first quarter 2024 results within Medical Laboratories industry 27 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 3232, from total ranking in the previous quarter at 3596.
Learn about Gross Margin
DMTK's Gross Profit Margin first quarter 2024 Company Ranking
Within: No.
Medical Laboratories Industry # 28
Healthcare Sector # 477
Overall # 3190

Gross Profit Margin Statistics
High Average Low
22.74 % 12.56 % 0.27 %
(Mar 31 2020)   (Jun 30 2023)


DMTK Gross Income Trends • More of DMTK's Profitabilty Ratios • DMTK Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
DMTK's Cumulative Gross Profit Margin
Medical Laboratories Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
DMTK's Gross Profit Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for DMTK's Competitors
Gross Profit Margin Profit Margin for Dermtech Inc 's Suppliers
Gross Profit Margin Profit Margin for DMTK's Customers

You may also want to know
DMTK's Annual Growth Rates DMTK's Profitability Ratios DMTK's Asset Turnover Ratio DMTK's Dividend Growth
DMTK's Roe DMTK's Valuation Ratios DMTK's Financial Strength Ratios DMTK's Gross Profit Growth
DMTK's Roa DMTK's Inventory Turnover Ratio DMTK's Growth Rates DMTK's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Mar 31 2024, within Medical Laboratories Industry Gross Profit MarginMar 31 2024 MRQ Gross ProfitMar 31 2024 MRQ Revenue
Ge Healthcare Technologies Inc   49.16 %$ 1,902.000  Millions$ 3,869.000  Millions
American Shared Hospital Services  41.67 %$ 2.143  Millions$ 5.143  Millions
Psychemedics Corporation  41.43 %$ 2.122  Millions$ 5.122  Millions
Iqvia Holdings Inc   34.60 %$ 1,293.000  Millions$ 3,737.000  Millions
Fulgent Genetics Inc   34.48 %$ 22.104  Millions$ 64.104  Millions
Charles River Laboratories International inc   34.09 %$ 344.843  Millions$ 1,011.560  Millions
Quest Diagnostics Inc  32.59 %$ 771.000  Millions$ 2,366.000  Millions
Medpace Holdings Inc   30.36 %$ 155.142  Millions$ 511.044  Millions
Labcorp Holdings Inc   28.25 %$ 897.300  Millions$ 3,176.600  Millions
Personalis Inc   28.13 %$ 5.493  Millions$ 19.525  Millions
Dermtech Inc   19.20 %$ 0.713  Millions$ 3.713  Millions
Fortrea Holdings Inc   16.30 %$ 107.900  Millions$ 662.100  Millions
Bionexus Gene Lab Corp   15.33 %$ 0.365  Millions$ 2.382  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.